Phase I Safety and Biodistribution Study of 124I-PEG-AVP0458 Diabody in Patients with TAG-72 Positive Ovarian and Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs 124I-PEG AVP 0458 diabody (Primary)
- Indications Ovarian cancer; Prostate cancer
- Focus Adverse reactions; First in man
- Sponsors Avipep
- 21 Apr 2015 New trial record
- 17 Apr 2015 Status changed from recruiting to completed, according to an Avipep media release.
- 17 Apr 2015 Results presented at American Association for Cancer Research (AACR) annual meeting, according to an Avipep media release.